Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate

Wilson, Andrew M., Sims, Erika J., Orr, Linda C. and Lipworth, Brian J. (1999) Differences in lung bioavailability between HFA and CFC formulations of fluticasone propionate. Lancet, 354 (9187). pp. 1357-1358. ISSN 1474-547X

Full text not available from this repository. (Request a copy)

Item Type:	Article
Additional Information:	Source:RK Note:
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Respiratory and Airways Group Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Centres > Population Health Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:12
Last Modified:	13 Nov 2023 16:55
URI:	https://ueaeprints.uea.ac.uk/id/eprint/14705
DOI:	10.1016/S0140-6736(99)03581-3

Actions (login required)

View Item